Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BodyLogicMD vs Harbor

BodyLogicMD
Graded #262

Lower grade

vs+8.899999999999999
Harbor
Graded #85

Higher grade

The verdict

Harbor takes it — 72/100 to 63.1/100.

Harbor grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHarbor +1
73
74
Dose & formulationHarbor +24
40
64
Clinical oversightHarbor +13
76
89
Labs & monitoringBodyLogicMD +1
64
63
FulfillmentHarbor +21
60
81
Contract termsBodyLogicMD +14
61
47
BodyLogicMD · left barHarbor · right bar

The numbers

MetricBodyLogicMDHarbor
WeighScore63.1/10072/100
GradeCC
Scorecard rank#262#85
SemaglutideNot disclosed$99/mo (starting dose, compounded)
TirzepatideNot disclosed$149/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
BodyLogicMD

Graded #262 · C

Strengths

  • Established since 2003 with board-certified specialists and a national network of local clinics plus telehealth
  • Integrates GLP-1 weight management with bioidentical hormone therapy and lab-based, whole-person protocols
  • Transparent $79/month membership, no insurance required, cancel anytime

Where it loses points

  • GLP-1 medication cost is not published — only the $79 membership fee is shown; drug type (compounded vs brand) not stated
  • Weight loss is secondary to the hormone-therapy core; not a GLP-1-first telehealth
  • State availability and dispensing pharmacy are not disclosed on the marketing site
Harbor

Graded #85 · C

Strengths

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

Where it loses points

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard